Jaundice - investigation of prolonged
This document is only valid for the day on which it is accessed. Please read our disclaimer.
Prolonged jaundice = Jaundice persisting for more than 14 days.
Children with clinically apparent jaundice present after 14 days of life require:
- Clinical review including examination of stool colour
- Conjugated and total bilirubin measured
Any delay in follow-up for children with neonatal jaundice can lead to poor long term outcomes.
Primary investigation of prolonged jaundice will include: feeding history, examination of the baby, examination of stool colour (acholic stools are highly characteristic of cholestasis in infancy). Initial laboratory tests should include:
- Bilirubin (total & direct (conjugated)). Bilirubin fractionation is the most important test in any infant who has more than two weeks of jaundice.
- Urine (for infection and reducing substances)
- and possibly a G6PD screen.
- Total conjugated bilirubin < 20 umol/L and
- Conjugated bilirubin <20% total bilirubin
Children with unconjugated hyperbilirubinaemia require assessment for underlying diagnosis and therapy.
- Clinical assessment - sepsis
- Does the child require phototherapy?
- Urine for Dipstick +- culture?
- Consider FBC and film/ G6PD/ Coombs for haemolysis
- Review maternal blood group for ABO/ rhesus incompatibility
- Total conjugated bilirubin > 20 umol/L or
- Conjugated bilirubin >20% total bilirubin
Any patient with conjugated hyperbilirubinaemia will be urgently reviewed by the Paediatric Gastroenterology/Hepatology service.
Important clinic issues
- Most children with conjugated hyperbilirubinaemia look well but may have important disease.
- Stool colour - pale stool and dark urine suggests Biliary Atresia
- All children with conjugated hyperbilirubinamia require additional Vitamin A,D,E,K
Causes of neonatal cholestasis
Disorders in bold are more common or have specific therapy available
|Bile duct abnormalities||Endocrine disorders||Inherited and metabolic disorders|
Spontaneous perforation of bile ducts
Neonatal sclerosing cholangitis
Bile acid synthesis disorders
Progressive familial intrahepatic cholestasis
Neimann-Pick type C
Congenital disorders of glycosylation
Fatty acid oxidation disorders
Hereditary Fructose Intolerance
Urinary tract infection
(toxoplasmosis, rubella, CMV, herpes viruses)
Human Herpes virus-6, Varicella-zoster
HIV, Hepatitis B
Echo, Adeno, Coxsackie-virus
Foetal alcohol syndrome
|Vascular Disorders||Chromosomal Disorders||Miscellaneous|
Congestive heart failure
|Trisomy 21, 13, 18
ARC syndrome (Arthrogryposis, renal tubular dysfunction and cholestasis)
Adapted from McKiernan 2002
Flow Chart for Investigation of Neonatal Cholestasis
- Acholic stools are highly characteristic of cholestasis in infancy.
- Bilirubin fractionation is the most important test in any infant who has more than two weeks of jaundice.
- Liver enzymes are of limited help to differentiate between hepatocellular and cholestatic liver injury.
- Synthetic liver function is best assessed by albumin level and clotting function. Untreated hypothrombinaemia may lead to spontaneous bleeding and intracranial haemorrhage.
First line investigations conjugated Hyperbilirubinaemia
|FBC and blood film|
|Total and conjugated bilirubin|
|AST, ALT, GGT, ALP|
|Blood group and coombs|
|T4 and TSH|
|α1 Antitrypsin phenotype (not level)|
|Cholesterol / triglycerides|
|INR/ APTT/ Fibrinogen|
|Blood sugar q4 hours first 24hours|
|Guthrie card result review|
|Maternal toxoplasma serology|
|Maternal Syphilis status|
|Maternal Rubella status|
|Maternal Hepatitis B status|
Second line investigations conjugated Hyperbilirubinaemia
|Urine organic acids|
|Urine amino acids|
|Serum amino acids|
|Herpes simplex PCR
(if clinically suspected)
|Hepatitis A Virus IgM|
|Epstein Barr Virus serology|
|Urine calcium/Phosphate creatinine ratio|
Download printable pdf of Second Line Investigations
Third line investigations conjugated Hyperbilirubinaemia
(repeat if normal & suspect diagnosis)
|Urine bile acids|
|Very long chain fatty acids|
|White Blood Cell enzymes if indicated|
|Muscle/ skin biopsy|
|Transferrin Isoelectric Focusing|
|Bone Marrow aspirate|
- All infants with conjugated hyperbilirubinaemia are started on Vit A, D, E, K
- Early consideration for starting MCT based formula (peptijunior)
Fat Soluble Vitamin Supplementation
All infants undergoing investigation of conjugated hyperbilirubinaemia should commence fat-soluble vitamin supplementation as soon as possible.
|Available preparation: Vitadol C® = 2000 micrograms vitamin A per gram = 1 ml =7500 IU|
|Starting dose is 1ml once daily|
|NB: Vitadol C® is only partially subsidised in the community; families should be informed they will be required to pay a part charge for this medicine.|
|Starting dose = 30-50 nanograms/kg once a day rounded to nearest 100 nanograms|
|Available preparation = Alfacalcidol (One-Alpha drops®) = 100 nanograms of 1-alpha-OH vitamin D3 per drop.|
|NB: This preparation should be prescribed in drops.|
|Starting dose = 50 mg (68 IU) once a day.|
|Available preparation = d-alpha-tocopheryl acetate (Micelle E®) = 156 IU/ml|
|Suggested dose is therefore 0.5 ml once daily.|
|NB: SPECIAL AUTHORITY is required for vitamin E administration and will be completed by the child's paediatrician prior to the child leaving hospital.|
|Suggested dose = 2.5 mg once a day|
|This is ¼ of an adult 10 mg Konakion tablet which can be crushed and mixed with water|
Mckiernan P. Neonatal cholestasis. Seminars in Neonatology. 2002 7 (2): 153 - 165
Did you find this information helpful?
- Date last published: 01 April 2010
- Document type: Clinical Guideline
- Services responsible: Paediatric Gastroenterology/Hepatology
- Author(s): Simon Chin, Stephen Mouat
- Editor: Greg Williams
- Review frequency: 2 years
SIGN UP TO RECEIVE GUIDELINE UPDATES
Subscribe below if you want us to let you know about new or updated guidelines
More From Starship
We welcome your involvement. Find out what guidelines are currently in development or under review. Find out more...
Read about the governance process around the Starship Clinical Guidelines and how to format guidelines in development.